(Q40442478)

20 September 2017

Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death (English)

1 reference

20 September 2017

0 references

Karl-Friedrich Becker

7

1 reference

Reingard Senekowitsch-Schmidtke

20 September 2017

Markus Schwaiger

11

0 references

12

object named as

Reingard Senekowitsch-Schmidtke

1 reference

20 September 2017

1

Christof Seidl

1 reference

20 September 2017

8

Christos Apostolidis

1 reference

20 September 2017

Hedwig Schröck

2

1 reference

20 September 2017

Sabine Seidenschwang

3

1 reference

20 September 2017

Roswitha Beck

4

1 reference

20 September 2017

Ernst Schmid

5

1 reference

20 September 2017

Michael Abend

6

1 reference

20 September 2017

Tuomo K Nikula

9

1 reference

20 September 2017

Elisabeth Kremmer

10

1 reference

20 September 2017

2 October 2004

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

20 September 2017

1 reference

20 September 2017

32

1 reference

20 September 2017

3

1 reference

20 September 2017

274-285

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-004-1653-3

20 September 2017

0 references

cites work

Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-004-1653-3

E-cadherin gene mutations provide clues to diffuse type gastric carcinomas

21 January 2018

1 reference

12 December 2020

Comparison of the Radiotoxicity of Two Alpha-Particle-Emitting Immunoconjugates, Terbium-149 and Bismuth-213, Directed against a Tumor-Specific, Exon 9 Deleted (d9) E-Cadherin Adhesion Protein

1 reference

12 December 2020

Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma.

1 reference

12 December 2020

Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells.

1 reference

12 December 2020

Mutations of the human E-cadherin (CDH1) gene.

1 reference

12 December 2020

Fas-induced activation of the cell death-related protease CPP32 Is inhibited by Bcl-2 and by ICE family protease inhibitors

1 reference

12 December 2020

Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies

1 reference

12 December 2020

Correlation of micronucleus and apoptosis assays with reproductive cell death can be improved by considering other modes of death

1 reference

12 December 2020

A serine protease is involved in the initiation of DNA damage-induced apoptosis

1 reference

12 December 2020

Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis

1 reference

12 December 2020

Low and high LET radiation‐induced apoptosis in M059J and M059K cells

1 reference

12 December 2020

Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials

1 reference

12 December 2020

Rapid induction of apoptosis in human gastric cancer cell lines by sorbitol

1 reference

12 December 2020

Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry.

1 reference

12 December 2020

Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin

1 reference

12 December 2020

Radioimmunotherapy of small-volume disease of metastatic colorectal cancer

1 reference

12 December 2020

213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model

1 reference

12 December 2020

The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism.

1 reference

12 December 2020

Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody

1 reference

12 December 2020

Current developments in SELDI affinity technology

1 reference

12 December 2020

Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation

1 reference

12 December 2020

Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma

1 reference

12 December 2020

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

12 December 2020

Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer

1 reference

12 December 2020

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

1 reference

12 December 2020

Targeted alpha particle immunotherapy for myeloid leukemia

1 reference

12 December 2020

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

1 reference

12 December 2020

Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology

1 reference

12 December 2020

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies

1 reference

12 December 2020

Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract.

1 reference

12 December 2020

Measurement of intracellular dna double-strand break induction and rejoining along the track of carbon and neon particle beams in water

1 reference

12 December 2020

Reasons to reconsider the significance of apoptosis for cancer therapy

1 reference

12 December 2020

Tumor therapy with targeted atomic nanogenerators

1 reference

12 December 2020

Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation

1 reference

12 December 2020

Advancing role of radiolabeled antibodies in the therapy of cancer

1 reference

12 December 2020

A proapoptotic peptide for the treatment of solid tumors

1 reference

12 December 2020

Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells

1 reference

12 December 2020

High-LET radiations induce a large proportion of non-rejoining DNA breaks

1 reference

12 December 2020

Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis?

1 reference

12 December 2020

Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model

1 reference

12 December 2020

Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy

1 reference

12 December 2020

Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis.

1 reference

12 December 2020

In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.

1 reference

12 December 2020

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

1 reference

12 December 2020

131I radioconjugated antibodies for the locoregional radioimmunotherapy of high-grade malignant glioma--phase I and II study

1 reference

12 December 2020

General aspects of the cellular response to low- and high-LET radiation

1 reference

12 December 2020

The role of p53 in determining sensitivity to radiotherapy

1 reference

12 December 2020

Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis

1 reference

12 December 2020

Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukaemia cells

1 reference

12 December 2020

Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide, bismuth 213.

1 reference

12 December 2020

Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells

1 reference

12 December 2020

Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody

1 reference

12 December 2020

10.1007/S00259-004-1653-3

Identifiers

DOI

1 reference

20 September 2017

1 reference